Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Neovasc Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA November 2, 2020

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Neovasc, Inc. (NVCN) on Behalf of Investors

Business Wire November 2, 2020

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Neovasc Inc. (NVCN) Investigation

ACCESSWIRE IA November 2, 2020

Rosen, Trusted Investor Counsel, Announces Investigation of Securities Claims Against Neovasc Inc. - NVCN

Newsfile October 31, 2020

The Law Offices of Frank R. Cruz Announces Investigation of Neovasc, Inc (NVCN) on Behalf of Investors

Business Wire October 31, 2020

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Neovasc Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire October 30, 2020

CORRECTING and REPLACING NVCN Equity Alert: Rosen Law Firm Announces Investigation of Securities Claims Against Neovasc Inc. - NVCN

Business Wire October 30, 2020

NVCN Equity Alert: Rosen Law Firm Announces Investigation of Securities Claims Against Neovasc Inc. - NVCN

Business Wire October 29, 2020

Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer(TM) Medical Device for the Treatment of Refractory Angina

Newsfile October 28, 2020

Neovasc to Report Third Quarter Financial Results on November 5, 2020

GlobeNewswire October 22, 2020

Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020

Newsfile October 13, 2020

Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference

Newsfile September 8, 2020

Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

GlobeNewswire September 3, 2020

Neovasc Announces Partial Prepayment of Convertible Debenture

GlobeNewswire August 17, 2020

Neovasc Provides Corporate Update

GlobeNewswire August 13, 2020

Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire August 12, 2020

Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire August 10, 2020

Neovasc Announces Second Quarter Financial Results

Newsfile August 6, 2020

Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper

GlobeNewswire July 24, 2020

Neovasc Announces Partial Prepayment of Convertible Debenture

Newsfile July 23, 2020